Melanotan II

Melanocortin (libido, tanning, appetite)Not approved; health-agency warnings

Also known as: MT-2; related: afamelanotide (Scenesse)

A tanning peptide sold online. Its cousin afamelanotide is approved for a rare light-sensitivity disease.

Educational reference, not medical advice. Many compounds here are not approved, and products sold as research chemicals are not checked for purity. Plan any use with a licensed clinician.

How it works

Activates melanocortin receptors (MC1R for pigment, MC4R for libido and appetite).

Evidence by goal

GoalGradeWhat the grade means
Skin, hair & appearanceCLimited human data, case series or practitioner reports
Libido & sexual functionCLimited human data, case series or practitioner reports

At a glance

Route
Subcutaneous or nasal
Half-life
About 1 hour

Reported dosing

Loading: 0.25 to 0.5 mg daily until desired color. Maintenance: 0.5 mg 1 to 2 times weekly (user reports).

Timing: Evening, to sleep through nausea.

Cycle: Loading 1 to 3 weeks, then maintenance.

From approved labels where they exist, otherwise from published trials and practitioner reports.

Side effects

  • Nausea, flushing, yawning
  • Spontaneous erections
  • New or darkening moles

Who should avoid it

  • Personal or family history of melanoma
  • Many atypical moles
  • High blood pressure

Often combined with

Do not combine with PT-141.

Key findings

Case reports link it to changing moles and melanoma. Afamelanotide (16 mg implant every 2 months) is approved for erythropoietic protoporphyria.

Where it is legal (Oct 2026)

USNot approved
CanadaNot approved
MexicoNot approved
EUNot approved

Health Canada, US, UK and Australian regulators have issued public warnings.

Sources

Open Melanotan II in the Peptide Guide Compare all peptides by goal

Last reviewed November 2026. Regulatory status reflects the US unless noted and changes often.

Natoorales and e4life.io (Mexico residency and immigration help) are sister businesses founded by Ian Kain.

Scroll to Top